Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The latest for advanced breast cancer

Dr Hope Rugo – University of San Francisco, California USA

The latest for advanced breast cancer ( Dr Hope Rugo – University of San Francisco, California USA )

The latest for Multiple Myeloma

Prof Paul Richardson - Dana Farber Institute, Boston, USA

The latest for Multiple Myeloma ( Prof Paul Richardson - Dana Farber Institute, Boston, USA )

Myelodysplastic syndrome drug development and combination therapy

Prof Valeria Santini – University of Florence, Italy

Myelodysplastic syndrome drug development and combination therapy ( Prof Valeria Santini – University of Florence, Italy )

Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI...

Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA

Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765 ( Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA )

Update and new perspectives in the management of MDS

Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA

Update and new perspectives in the management of MDS ( Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA )

New data on aggressive B cell lymphoma

Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA

New data on aggressive B cell lymphoma ( Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA )

Causes and drug development in ataxia telangiectasia

Dr Richard Gatti – David Geffen School of Medicine UCLA, USA

Causes and drug development in ataxia telangiectasia ( Dr Richard Gatti – David Geffen School of Medicine UCLA, USA )

Update on the phase III VISTA trial

Dr Jesus San Miguel – University Hospital of Salamanca, Spain

Update on the phase III VISTA trial ( Dr Jesus San Miguel – University Hospital of Salamanca, Spain )

Update on the development of proteasome inhibitors

Dr Philip McCarthy – Roswell Park Cancer Institute, USA

Update on the development of proteasome inhibitors ( Dr Philip McCarthy – Roswell Park Cancer Institute, USA )

Romidepsin treatment in peripheral T cell lymphoma and subsets

Dr Francine Foss – Yale School of Medicine, Connecticut, USA

Romidepsin treatment in peripheral T cell lymphoma and subsets ( Dr Francine Foss – Yale School of Medicine, Connecticut, USA )

Optimal treatment schedule for pomalidomide in multiple myeloma

Prof Gareth Morgan, Royal Marsden Hospital, London, UK and Dr Xavier Leleu...

Optimal treatment schedule for pomalidomide in multiple myeloma ( Prof Gareth Morgan, Royal Marsden Hospital, London, UK and Dr Xavier Leleu, Hôpital Huriez, CHRU Lille, France )

Indolent non-Hodgkin’s Lymphoma in 2011: A game changing year

Dr Mathias Rummel - University Hospital, Giessen, Germany, Prof John Gribben –...

Indolent non-Hodgkin’s Lymphoma in 2011: A game changing year ( Dr Mathias Rummel - University Hospital, Giessen, Germany, Prof John Gribben – Barts and The London Trust Cancer Centre, UK and Prof Gilles Salles - Universite Claude Bernard Lyon, France )

More from ecancer